Skip to main content
Log in

New oral antihyperglycaemic agents expand armamentarium in the battle against type 2 diabetes mellitus

  • New Drugs and Disease Management
  • Published:
Drugs & Therapy Perspectives Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Scheen AJ, Lefèbvre PJ. Oral antidiabetic agents: a guide to selection. Drugs 1998 Feb; 55(2): 225–36

    Article  PubMed  CAS  Google Scholar 

  2. Wills C, Page S. Oral antidiabetic drugs: role in the management of type 2 diabetes. Prescriber 1998 May 19; 79, 82–3

    Google Scholar 

  3. British National Formulary No. 35. London: The Pharmaceutical Press, 1998 Mar: 303–6

  4. PDR Generics. 4th ed. Montvale (NJ): Medical Economics, 1998: 2752–6

  5. Scheen AJ, Lefèbvre PJ. Pathophysiology of type 2 diabetes. In: Kuhlmann J, Puls W, editors. Handbook of experimental pharmacology: oral antidiabetics. Berlin: Springer Verlag, 1995: 7–42

    Google Scholar 

  6. Brown A. Diabetes mellitus (3): management of non-insulin-dependent diabetes mellitus. Pharm J 1998 Jun 20; 260: 905–7

    Google Scholar 

  7. Sirtori CR, Pasik C. Re-evaluation of a biguanide, metformin: mechanism of action and tolerability. Pharmacol Res 1994; 30: 187–228

    Article  PubMed  CAS  Google Scholar 

  8. Henry RR. Thiazolidinediones. Endocrinol Metab Clin North Am 1997; 26: 553–73

    Article  PubMed  CAS  Google Scholar 

  9. Riddle MC. Tactics for type II diabetes. Endocrinol Metab Clin North Am 1997; 26: 659–77

    Article  PubMed  CAS  Google Scholar 

  10. United Kingdom Prospective Diabetes Study Group. UK Prospective Diabetes Study 13: relative efficacy of randomly allocated diet, sulfonylurea, insulin or metformin in patients with newly diagnosed non-insulin-dependent diabetes followed for three years. BMJ 1995; 310: 83–8

    Article  Google Scholar 

  11. United Kingdom Prospective Diabetes Study Group. UK Prospective Diabetes Study 16: Overview of 6 years’ therapy of type II diabetes: a progressive disease. Diabetes 1995; 44: 1249–58

    Article  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

New oral antihyperglycaemic agents expand armamentarium in the battle against type 2 diabetes mellitus. Drugs Ther. Perspect 12, 6–10 (1998). https://doi.org/10.2165/00042310-199812070-00002

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00042310-199812070-00002

Keywords

Navigation